ID   RPM1_ARATH              Reviewed;         926 AA.
AC   Q39214;
DT   11-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-DEC-2020, entry version 151.
DE   RecName: Full=Disease resistance protein RPM1;
DE   AltName: Full=Resistance to Pseudomonas syringae protein 3;
GN   Name=RPM1; Synonyms=RPS3; OrderedLocusNames=At3g07040; ORFNames=F17A9.20;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND MUTANTS RPS3-2 AND RPS3-4.
RC   STRAIN=cv. Columbia;
RX   PubMed=7638602; DOI=10.1126/science.7638602;
RA   Grant M.R., Godiard L., Straube E., Ashfield T., Lewald J., Stattler A.,
RA   Innes R.W., Dangl J.L.;
RT   "Structure of the Arabidopsis RPM1 gene enabling dual specificity disease
RT   resistance.";
RL   Science 269:843-846(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130713; DOI=10.1038/35048706;
RA   Salanoubat M., Lemcke K., Rieger M., Ansorge W., Unseld M., Fartmann B.,
RA   Valle G., Bloecker H., Perez-Alonso M., Obermaier B., Delseny M.,
RA   Boutry M., Grivell L.A., Mache R., Puigdomenech P., De Simone V.,
RA   Choisne N., Artiguenave F., Robert C., Brottier P., Wincker P.,
RA   Cattolico L., Weissenbach J., Saurin W., Quetier F., Schaefer M.,
RA   Mueller-Auer S., Gabel C., Fuchs M., Benes V., Wurmbach E., Drzonek H.,
RA   Erfle H., Jordan N., Bangert S., Wiedelmann R., Kranz H., Voss H.,
RA   Holland R., Brandt P., Nyakatura G., Vezzi A., D'Angelo M., Pallavicini A.,
RA   Toppo S., Simionati B., Conrad A., Hornischer K., Kauer G., Loehnert T.-H.,
RA   Nordsiek G., Reichelt J., Scharfe M., Schoen O., Bargues M., Terol J.,
RA   Climent J., Navarro P., Collado C., Perez-Perez A., Ottenwaelder B.,
RA   Duchemin D., Cooke R., Laudie M., Berger-Llauro C., Purnelle B., Masuy D.,
RA   de Haan M., Maarse A.C., Alcaraz J.-P., Cottet A., Casacuberta E.,
RA   Monfort A., Argiriou A., Flores M., Liguori R., Vitale D., Mannhaupt G.,
RA   Haase D., Schoof H., Rudd S., Zaccaria P., Mewes H.-W., Mayer K.F.X.,
RA   Kaul S., Town C.D., Koo H.L., Tallon L.J., Jenkins J., Rooney T., Rizzo M.,
RA   Walts A., Utterback T., Fujii C.Y., Shea T.P., Creasy T.H., Haas B.,
RA   Maiti R., Wu D., Peterson J., Van Aken S., Pai G., Militscher J.,
RA   Sellers P., Gill J.E., Feldblyum T.V., Preuss D., Lin X., Nierman W.C.,
RA   Salzberg S.L., White O., Venter J.C., Fraser C.M., Kaneko T., Nakamura Y.,
RA   Sato S., Kato T., Asamizu E., Sasamoto S., Kimura T., Idesawa K.,
RA   Kawashima K., Kishida Y., Kiyokawa C., Kohara M., Matsumoto M., Matsuno A.,
RA   Muraki A., Nakayama S., Nakazaki N., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Tabata S.;
RT   "Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana.";
RL   Nature 408:820-822(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [4]
RP   SUBCELLULAR LOCATION, AND DEGRADATION.
RX   PubMed=9861059; DOI=10.1073/pnas.95.26.15849;
RA   Boyes D.C., Nam J., Dangl J.L.;
RT   "The Arabidopsis thaliana RPM1 disease resistance gene product is a
RT   peripheral plasma membrane protein that is degraded coincident with the
RT   hypersensitive response.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:15849-15854(1998).
RN   [5]
RP   MUTAGENESIS OF SER-43; PRO-105; GLY-174; LEU-186; GLY-203; GLY-205;
RP   ALA-211; VAL-219; GLU-247; VAL-269; LEU-272; THR-290; LEU-301; GLY-307;
RP   THR-313; GLY-325; GLU-340; LEU-344; ALA-379; GLY-384; GLU-395; SER-439;
RP   PRO-442; PRO-464; GLY-467; GLU-471; ALA-474; PRO-494; ARG-497; PRO-498;
RP   SER-515; PRO-620; SER-738; GLY-766; LEU-778; LEU-781; ARG-787; ASN-812;
RP   LEU-852 AND LEU-924.
RX   PubMed=11884685; DOI=10.1105/tpc.010393;
RA   Tornero P., Chao R.A., Luthin W.N., Goff S.A., Dangl J.L.;
RT   "Large-scale structure-function analysis of the Arabidopsis RPM1 disease
RT   resistance protein.";
RL   Plant Cell 14:435-450(2002).
RN   [6]
RP   INTERACTION WITH TIP49A.
RX   PubMed=12062092; DOI=10.1016/s1534-5807(02)00174-0;
RA   Holt B.F. III, Boyes D.C., Ellerstroem M., Siefers N., Wiig A.,
RA   Kauffman S., Grant M.R., Dangl J.L.;
RT   "An evolutionarily conserved mediator of plant disease resistance gene
RT   function is required for normal Arabidopsis development.";
RL   Dev. Cell 2:807-817(2002).
RN   [7]
RP   INTERACTION WITH RIN4.
RX   PubMed=11955429; DOI=10.1016/s0092-8674(02)00661-x;
RA   Mackey D., Holt B.F. III, Wiig A., Dangl J.L.;
RT   "RIN4 interacts with Pseudomonas syringae type III effector molecules and
RT   is required for RPM1-mediated resistance in Arabidopsis.";
RL   Cell 108:743-754(2002).
RN   [8]
RP   INTERACTION WITH RIN2 AND RIN3.
RX   PubMed=16212605; DOI=10.1111/j.1365-313x.2005.02525.x;
RA   Kawasaki T., Nam J., Boyes D.C., Holt B.F. III, Hubert D.A., Wiig A.,
RA   Dangl J.L.;
RT   "A duplicated pair of Arabidopsis RING-finger E3 ligases contribute to the
RT   RPM1- and RPS2-mediated hypersensitive response.";
RL   Plant J. 44:258-270(2005).
RN   [9]
RP   INTERACTION WITH MORC1/CRT1.
RX   PubMed=20332379; DOI=10.1105/tpc.109.071662;
RA   Kang H.-G., Oh C.-S., Sato M., Katagiri F., Glazebrook J., Takahashi H.,
RA   Kachroo P., Martin G.B., Klessig D.F.;
RT   "Endosome-associated CRT1 functions early in resistance gene-mediated
RT   defense signaling in Arabidopsis and tobacco.";
RL   Plant Cell 22:918-936(2010).
CC   -!- FUNCTION: Disease resistance (R) protein that specifically recognizes
CC       the AvrRpm1 type III effector avirulence protein from Pseudomonas
CC       syringae. Resistance proteins guard the plant against pathogens that
CC       contain an appropriate avirulence protein via an indirect interaction
CC       with this avirulence protein. That triggers a defense system including
CC       the hypersensitive response, which restricts the pathogen growth. Acts
CC       via its interaction with RIN4, and probably triggers the plant
CC       resistance when RIN4 is phosphorylated by AvrRpm1. It is then degraded
CC       at the onset of the hypersensitive response.
CC   -!- SUBUNIT: Interacts directly with RIN4 via its N-terminal region.
CC       Interacts (via N-terminus) with RIN2 and RIN3 (via C-terminus).
CC       Interacts with TIP49A, a protein known to interact with the TATA
CC       binding protein complex (TBP) (PubMed:11955429, PubMed:12062092,
CC       PubMed:16212605). Binds to MORC1/CRT1 (PubMed:20332379).
CC       {ECO:0000269|PubMed:11955429, ECO:0000269|PubMed:12062092,
CC       ECO:0000269|PubMed:16212605, ECO:0000269|PubMed:20332379}.
CC   -!- SUBCELLULAR LOCATION: Endomembrane system {ECO:0000269|PubMed:9861059};
CC       Peripheral membrane protein {ECO:0000269|PubMed:9861059}.
CC   -!- DOMAIN: The LRR repeats probably act as specificity determinant of
CC       pathogen recognition.
CC   -!- SIMILARITY: Belongs to the disease resistance NB-LRR family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIB-LRRS; Note=Functional and comparative genomics
CC       of disease resistance gene homologs;
CC       URL="http://niblrrs.ucdavis.edu";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X87851; CAA61131.1; -; Genomic_DNA.
DR   EMBL; AC016827; AAF27008.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE74492.1; -; Genomic_DNA.
DR   PIR; A57072; A57072.
DR   RefSeq; NP_187360.1; NM_111584.3.
DR   BioGRID; 5224; 7.
DR   STRING; 3702.AT3G07040.1; -.
DR   iPTMnet; Q39214; -.
DR   PaxDb; Q39214; -.
DR   PRIDE; Q39214; -.
DR   ProteomicsDB; 228192; -.
DR   EnsemblPlants; AT3G07040.1; AT3G07040.1; AT3G07040.
DR   GeneID; 819889; -.
DR   Gramene; AT3G07040.1; AT3G07040.1; AT3G07040.
DR   KEGG; ath:AT3G07040; -.
DR   Araport; AT3G07040; -.
DR   TAIR; locus:2077572; AT3G07040.
DR   eggNOG; KOG4658; Eukaryota.
DR   HOGENOM; CLU_000837_25_4_1; -.
DR   InParanoid; Q39214; -.
DR   OMA; MWARHSI; -.
DR   OrthoDB; 176572at2759; -.
DR   PhylomeDB; Q39214; -.
DR   PRO; PR:Q39214; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; Q39214; baseline and differential.
DR   Genevisible; Q39214; AT.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0019897; C:extrinsic component of plasma membrane; IDA:CACAO.
DR   GO; GO:0005886; C:plasma membrane; IDA:TAIR.
DR   GO; GO:0043531; F:ADP binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000166; F:nucleotide binding; ISS:TAIR.
DR   GO; GO:0009626; P:plant-type hypersensitive response; IDA:TAIR.
DR   CDD; cd14798; RX-CC_like; 1.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR002182; NB-ARC.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR038005; RX-like_CC.
DR   InterPro; IPR041118; Rx_N.
DR   Pfam; PF00931; NB-ARC; 1.
DR   Pfam; PF18052; Rx_N; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Hypersensitive response; Leucine-rich repeat; Membrane;
KW   Nucleotide-binding; Plant defense; Reference proteome; Repeat.
FT   CHAIN           1..926
FT                   /note="Disease resistance protein RPM1"
FT                   /id="PRO_0000212717"
FT   DOMAIN          153..467
FT                   /note="NB-ARC"
FT   REPEAT          560..581
FT                   /note="LRR 1"
FT   REPEAT          582..603
FT                   /note="LRR 2"
FT   REPEAT          605..626
FT                   /note="LRR 3"
FT   REPEAT          628..650
FT                   /note="LRR 4"
FT   NP_BIND         200..207
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   REGION          10..45
FT                   /note="Leucine-zipper"
FT   MUTAGEN         43
FT                   /note="S->F: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         105
FT                   /note="P->S: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         174
FT                   /note="G->R: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         186
FT                   /note="L->F: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         203
FT                   /note="G->D,S: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         205
FT                   /note="G->R,E: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         211
FT                   /note="A->V: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         219
FT                   /note="V->M: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         247
FT                   /note="E->K: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         269
FT                   /note="V->M: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         272
FT                   /note="L->F: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         290
FT                   /note="T->I: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         301
FT                   /note="L->F: In rps3-2; loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         307
FT                   /note="G->E: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         313
FT                   /note="T->I: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         325
FT                   /note="G->E: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         340
FT                   /note="E->K: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         341
FT                   /note="A->V: Loss of function."
FT   MUTAGEN         344
FT                   /note="L->F: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         379
FT                   /note="A->V: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         384
FT                   /note="G->R: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         395
FT                   /note="E->K: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         439
FT                   /note="S->F: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         442
FT                   /note="P->L: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         464
FT                   /note="P->L: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         467
FT                   /note="G->R: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         471
FT                   /note="E->K: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         474
FT                   /note="A->T: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         494
FT                   /note="P->L: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         497
FT                   /note="R->Q: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         498
FT                   /note="P->L,S: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         515
FT                   /note="S->F: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         620
FT                   /note="P->S,L: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         738
FT                   /note="S->F: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         766
FT                   /note="G->E: In rps3-4; loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         778
FT                   /note="L->F: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         781
FT                   /note="L->F: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         787
FT                   /note="R->H: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         812
FT                   /note="N->I: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         852
FT                   /note="L->F: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
FT   MUTAGEN         924
FT                   /note="L->F: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11884685"
SQ   SEQUENCE   926 AA;  106883 MW;  E2B2D6613CB0FA0D CRC64;
     MASATVDFGI GRILSVLENE TLLLSGVHGE IDKMKKELLI MKSFLEDTHK HGGNGSTTTT
     TQLFQTFVAN TRDLAYQIED ILDEFGYHIH GYRSCAKIWR AFHFPRYMWA RHSIAQKLGM
     VNVMIQSISD SMKRYYHSEN YQAALLPPID DGDAKWVNNI SESSLFFSEN SLVGIDAPKG
     KLIGRLLSPE PQRIVVAVVG MGGSGKTTLS ANIFKSQSVR RHFESYAWVT ISKSYVIEDV
     FRTMIKEFYK EADTQIPAEL YSLGYRELVE KLVEYLQSKR YIVVLDDVWT TGLWREISIA
     LPDGIYGSRV MMTTRDMNVA SFPYGIGSTK HEIELLKEDE AWVLFSNKAF PASLEQCRTQ
     NLEPIARKLV ERCQGLPLAI ASLGSMMSTK KFESEWKKVY STLNWELNNN HELKIVRSIM
     FLSFNDLPYP LKRCFLYCSL FPVNYRMKRK RLIRMWMAQR FVEPIRGVKA EEVADSYLNE
     LVYRNMLQVI LWNPFGRPKA FKMHDVIWEI ALSVSKLERF CDVYNDDSDG DDAAETMENY
     GSRHLCIQKE MTPDSIRATN LHSLLVCSSA KHKMELLPSL NLLRALDLED SSISKLPDCL
     VTMFNLKYLN LSKTQVKELP KNFHKLVNLE TLNTKHSKIE ELPLGMWKLK KLRYLITFRR
     NEGHDSNWNY VLGTRVVPKI WQLKDLQVMD CFNAEDELIK NLGCMTQLTR ISLVMVRREH
     GRDLCDSLNK IKRIRFLSLT SIDEEEPLEI DDLIATASIE KLFLAGKLER VPSWFNTLQN
     LTYLGLRGSQ LQENAILSIQ TLPRLVWLSF YNAYMGPRLR FAQGFQNLKI LEIVQMKHLT
     EVVIEDGAMF ELQKLYVRAC RGLEYVPRGI ENLINLQELH LIHVSNQLVE RIRGEGSVDR
     SRVKHIPAIK HYFRTDNGSF YVSLSS
//
